Inicio › Cáncer de próstata › Distrito de Columbia › Washington
Ensayos clínicos de Cáncer de próstata en Washington, DC
38 estudios para Cáncer de próstata buscan participantes en centros de Washington y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy
ReclutandoFase 2
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
The Vanguard Study: Testing a New Way to Screen for Cancer
ReclutandoSe aceptan voluntarios sanos
- Walter Reed National Military Medical Center, Bethesda · A 7 mi de distancia
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation Therapy
ReclutandoEstudio observacional
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
ReclutandoFase 3
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
ReclutandoEstudio observacional
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Collection of Blood From Patients With Prostate Cancer
ReclutandoEstudio observacional
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- MedStar Georgetown University Hospital, Washington D.C.
- MedStar Washington Hospital Center, Washington D.C.
- Walter Reed National Military Medical Center, Bethesda · A 7 mi de distancia
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
ReclutandoFase 2
- MedStar Georgetown University Hospital, Washington D.C.
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Precision-Based Genomics in Prostate Cancer
ReclutandoEstudio observacional
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Collection of Blood From Patients With Cancer
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
ReclutandoFase 3
- MedStar Washington Hospital Center ( Site 0103), Washington D.C.
Prospective Monitoring of Subjects With Biochemically Recurrent Prostate Cancer Using 18FDCFPyL
ReclutandoEstudio observacional
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Care of the Prostate Cancer Patient and Prospective Procurement of Prostate Cancer Tissue
ReclutandoEstudio observacional
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
A Phase II Study Evaluating T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine PDS01ADC in Localized High and Intermediate Risk Prostate Cancer Treated With Androgen Deprivation Therapy
ReclutandoFase 2
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
ReclutandoFase 2
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumor
ReclutandoFase 2
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
ReclutandoFase 3
- The GW Medical Faculty Associates ( Site 0057), Washington D.C.
- Washington DC Veterans Affairs Medical Center ( Site 0056), Washington D.C.
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
ReclutandoFase 3
- George Washington University Medical Center, Washington D.C.
- UM Capital Region Medical Center, Largo · A 11 mi de distancia
Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer
ReclutandoEstudio observacional
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Enzalutamide and PDS01ADC in PET Positive Recurrent Prostate Cancer (pprPC) Without Testosterone Lowering Therapy
ReclutandoFase 2
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Men at High Genetic Risk for Prostate Cancer
ReclutandoEstudio observacional
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
ReclutandoFase 1/2
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer
Reclutando
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer
ReclutandoFase 2
- Lombardi Comprehensive Cancer Center, Georgetown University, Washington D.C.
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
ReclutandoFase 3
- Sibley Memorial Hospital, Washington D.C.
- Suburban Hospital, Bethesda · A 7 mi de distancia
FOG-001 in Locally Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer
ReclutandoFase 2
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
ReclutandoFase 3
- Sibley Memorial Hospital, Washington D.C.
- George Washington University Medical Center, Washington D.C.
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
ReclutandoFase 1
- Maryland Oncology Hematology, Silver Spring · A 7 mi de distancia
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- National Institutes of Health Clinical Center, Bethesda · A 7 mi de distancia
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
ReclutandoFase 4
- VA Medical Center, Washington D.C.
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Cancer Support Community Research & Training Institute, Washington D.C.
Clinical Trial of Approaches to Prostate Cancer Surgery
Reclutando
- Georgetown University, Washington D.C.
Castrate Resistant Prostate Cancer Enhertu Therapy
ReclutandoFase 2
- Washington DC VAMC, Washington D.C.
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
ReclutandoFase 2/3
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer
ReclutandoSe aceptan voluntarios sanos
- Howard University Hospital, Washington D.C.
- National Cancer Institute, Bethesda · A 7 mi de distancia
- Walter Reed National Military Medical Center, Bethesda · A 7 mi de distancia
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
ReclutandoEstudio observacional
- Massive Bio SYNERGY-AI site, Silver Spring · A 7 mi de distancia
- Massive Bio SYNERGY-AI site, Bethesda · A 7 mi de distancia
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
ReclutandoFase 3
- George Washington University Medical Center, Washington D.C.
Más información sobre Cáncer de próstata en MedlinePlus
Ensayos de Cáncer de próstata en otras ciudades
- New York City, NY103 estudios
- Houston, TX76 estudios
- Los Angeles, CA61 estudios
- Boston, MA59 estudios
- St. Louis, MO46 estudios
- Chicago, IL45 estudios
- San Francisco, CA45 estudios
- Philadelphia, PA44 estudios
- Baltimore, MD43 estudios
- Nashville, TN43 estudios
- Seattle, WA42 estudios
- Dallas, TX36 estudios
Otros estudios en Washington
- Cáncer (todos los tipos)58 estudios
- Cáncer de pulmón de células no pequeñas55 estudios
- Cáncer de seno46 estudios
- Cáncer metastásico43 estudios
- Cáncer de pulmón41 estudios
- Obesidad33 estudios
- Cáncer del colon y del recto29 estudios
- Enfermedad cardiovascular28 estudios
- Cáncer de vejiga26 estudios
- Leucemia mielógena aguda24 estudios
- Cáncer de ovario23 estudios
- Linfoma23 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.